COMMUNIQUÉS West-GlobeNewswire

Alpha Bites: Reviews, Ingredients, Studies and Where to Buy

05/02/2025 - 19:58

LAKELAND, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Alpha Bites also known as “AlphaBites“ arrives at a pivotal moment when countless men, facing declining stamina and confidence, seek innovative ways to recapture the [...]

New AFB Scholars Program Expands Opportunities for Blind Students

05/02/2025 - 21:56

ARLINGTON, Va., Feb. 05, 2025 (GLOBE NEWSWIRE) -- The American Foundation for the Blind (AFB) announced this week the launch of the AFB Scholars Program, which aims to provide substantial scholarships for students who [...]

Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

05/02/2025 - 22:00

SOUTH SAN FRANCISCO, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a [...]

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05/02/2025 - 22:00

WESTLAKE VILLAGE, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

05/02/2025 - 22:01

BURLINGTON, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric [...]

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

05/02/2025 - 22:01

– KOMET-001 registrational trial in R/R NPM1-m AML achieved primary CR/CRh endpoint; topline data submitted for presentation at an upcoming medical meeting – – NDA submission for ziftomenib on track for 2Q 2025 – – [...]

Ascendis Pharma to Report Full Year 2024 Financial Results and Provide Business Update on February 12, 2025

05/02/2025 - 22:01

COPENHAGEN, Denmark, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report full year 2024 financial results and provide a business update on Wednesday, February 12, 2025, [...]

Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares

05/02/2025 - 22:01

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog [...]

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

05/02/2025 - 22:04

TORONTO and HAIFA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (“ NurExone ” or the “ Company ”) is pleased to announce the formation of a U.S.-based [...]

Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC

05/02/2025 - 22:05

- Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and weight loss to subcutaneous administration - - RT-116 was well tolerated with no serious [...]

Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update

05/02/2025 - 22:05

Enhanced liquidity by $27.5 million through the issuance of 6.9 million common shares First quarter fiscal 2025 revenue declined 11.5% to $119.9 million Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, [...]

Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

05/02/2025 - 22:05

REDWOOD CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular [...]

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

05/02/2025 - 22:05

SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]

Cytek Biosciences to Participate in Upcoming Investor Conferences

05/02/2025 - 22:05

FREMONT, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor [...]

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025

05/02/2025 - 22:05

RADNOR, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD [...]

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

05/02/2025 - 22:05

FOSTER CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]

BriaCell Therapeutics Announces Closing of Public Offering

05/02/2025 - 22:05

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]

The Ensign Group Reports Fiscal Year and Fourth Quarter 2024 Results; Issues 2025 Earnings Guidance

05/02/2025 - 22:06

Conference Call and Webcast scheduled for tomorrow, February 6, 2025 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign [...]

DLH Reports Fiscal 2025 First Quarter Results

05/02/2025 - 22:15

Navigating Challenges in Company's Transformation Journey; Delivering Recent Wins and Growing Bid Pipeline to Improve Outlook for Organic Growth ATLANTA, Feb. 05, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: [...]